Zhibo Liu
Peking Union Medical College
12 Papers
4 Citations
Zhibo Liu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Retrospective cohort study. The author has an hindex of 6, co-authored 8 publications. Previous affiliations of Zhibo Liu include China-Japan Friendship Hospital & Capital Medical University.
Chat about Author
Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
26.9K
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
- 01 Jan 2020
TL;DR: Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
12.5K
Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study.
Guohui Fan,Guohui Fan,Chao Tu,Fei Zhou,Fei Zhou,Zhibo Liu,Zhibo Liu,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Yimin Wang,Yimin Wang,Yuan Wei,Hui Li,Hui Li,Xudong Wu,Jiuyang Xu,Sheng-jin Tu,Yi Zhang,Yi Zhang,Wenjuan Wu,Bin Cao,Bin Cao,Bin Cao +24 more
TL;DR: The aim of this study was to compare the accuracy of current score rules in hospitalised patients with COVID-19 pneumonia for predicting the risk of death and evaluate feasibility in improving medical decisions by adopting appropriate scores in clinical practice.
171
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.
Jiuyang Xu,Chaolin Huang,Guohui Fan,Guohui Fan,Zhibo Liu,Zhibo Liu,Lianhan Shang,Lianhan Shang,Lianhan Shang,Fei Zhou,Fei Zhou,Yeming Wang,Yeming Wang,Yeming Wang,Jiapei Yu,Luning Yang,Ke Xie,Ke Xie,Zhisheng Huang,Zhisheng Huang,Lixue Huang,Lixue Huang,Xiaoying Gu,Xiaoying Gu,Hui Li,Hui Li,Yi Zhang,Yi Zhang,Yimin Wang,Yimin Wang,Frederick G. Hayden,Peter Horby,Bin Cao,Chen Wang +33 more
TL;DR: The findings confirm the lack of an association between chronic receipt of renin-angiotensin system antagonists and severe outcomes of COVID-19 and patients should continue previous anti-hypertensive therapy until further evidence is available.
In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase.
Chunlei Wang,Jiankang Zhao,Zhibo Liu,Zhibo Liu,Zhibo Liu,Aihua Sun,Aihua Sun,Aihua Sun,Lingxiao Sun,Binbin Li,Binghuai Lu,Yingmei Liu,Bin Cao +12 more
TL;DR: In this paper, the in vivo evolution of carbapenem and ceftazidime-avibactam resistance by analyzing four longitudinal Klebsiella pneumoniae clinical isolates from a patient with pneumonia following antimicrobial treatment was described.